2022 SNMMI and SNMMI-TS Grants and Awards Recipients

2022 Grants and Awards Recipients (funded by the ERF)

Sam Gambhir, MD Trailblazer Award - Andrei Iagaru, MD, FACNM

Arthur M. Weis, PhD, Award in Radiation Dosimetry and Safety - Carlos Uribe-Munoz, PhD

Michael J. Welch Award - Weibo Cai, PhD, FAIMBE, FSNMMI

Michael J. Welch Postdoctoral Grant - Jay Wright, PhD

Mitzi & William Blahd, MD, Pilot Research Grant - Tahir Yusufaly, PhD

ERF SNMMI Molecular Imaging Research Grant for Junior Academic Faculty - n/a 2022

ERF SNMMI Postdoctoral Molecular Imaging Scholar Program - n/a 2022

SNMMI CMIIT Laboratory Professional Recognition Award for Contributions to Molecular Imaging - Teja Kalidindi, BS, MS

Bradley-Alavi Student Fellowships: Vibha Balaji and Abhijit Bhattaru

Paul C. Aebersold, PhD Award - Robert Mach, PhD

2022 Alavi-Mandell Awards Published in 2021 - 

Preclinical Development of F-OF-NB1 for Imaging GluN2B-Containing N-Methyl-d-Aspartate Receptors and Its Utility as a Biomarker for Amyotrophic Lateral Sclerosis

Hazem Ahmed, Rahel Wallimann, Ahmed Haider, Vahid Hosseini, Stefan Gruber, Marvin Robledo, Thi A.N. Nguyen, Adrienne Müller Herde, Irina Iten, Claudia Keller, Viola Vogel, Roger Schibli, Bernhard Wünsch, Linjing Mu, and Simon M. Ametamey

Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland

J Nucl Med 2021; 62:259–265

 

Transarterial Radioembolization Versus Systemic Treatment for Hepatocellular Carcinoma with Macrovascular Invasion: Analysis of the U.S. National Cancer Database

Joseph C. Ahn, Marie Lauzon, Michael Luu, Marc L. Friedman, Kambiz Kosari , Nicholas Nissen, Shelly C. Lu, Lewis R. Roberts, Amit G. Singal, and Ju Dong Yang

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota

J Nucl Med 2021; 62:57–58

 

Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake

Ian Alberts, Jan Niklas-Hünermund, Christos Sachpekidis, Helle Damgaard Zacho, Clemens Mingels, Lotte Dijkstra, Karl Peter Bohn, Tilman Läppchen, Eleni Gourni, Axel Rominger, and Ali Afshar-Oromieh

Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

J Nucl Med 2021; 62:1252–1257

 

Dose–Response and Dose–Toxicity Relationships for Glass 90Y Radioembolization in Patients with Liver Metastases from Colorectal Cancer

Ahmed A. Alsultan, Caren van Roekel, Maarten W. Barentsz, Maarten L.J. Smits, Britt Kunnen, Miriam Koopman, Arthur J.A.T. Braat, Rutger C.G. Bruijnen, Bart de Keizer, and Marnix G.E.H. Lam

Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands

J Nucl Med 2021; 62:1616–1623

 

Cyclotron-Produced 132La as a PET Imaging Surrogate for Therapeutic 225Ac

Eduardo Aluicio-Sarduy, Todd E. Barnhart, Jamey Weichert, Reinier Hernandez, and Jonathan W. Engle

Department of Medical Physics, University of Wisconsin–Madison, Madison, Wisconsin

J Nucl Med 2021; 62:1012–1015

The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study

Wesley R. Armstrong, Andrei Gafita, Shaojun Zhu, Pan Thin, Kathleen Nguyen, Rejah Alano, Stephanie Lira, Kiara Booker, Linda Gardner, Tristan Grogan, David Elashoff, Martin Allen-Auerbach, Magnus Dahlbom, Johannes Czernin, and Jeremie Calais

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California

J Nucl Med 2021; 62:1244–1251

 

Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery

Samaneh Azargoshasb, Krijn H.M. Houwing, Paul R. Roos, Sven I. van Leeuwen, Michael Boonekamp, Elio Mazzone, Kevin Bauwens, Paolo Dell’Oglio, Fijs W.B. van Leeuwen, and Matthias N. van Oosterom

Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands

J Nucl Med 2021; 62:1314–1317

 

GRPr Antagonist 68Ga-SB3 PET/CT Imaging of Primary Prostate Cancer in Therapy-Naïve Patients

Ingrid L. Bakker, Alida C. Fröberg, Martijn B. Busstra, J. Fred Verzijlbergen, Mark Konijnenberg, Geert J.L.H. van Leenders, Ivo G. Schoots, Erik de Blois, Wytske M. van Weerden, Simone U. Dalm, Theodosia Maina, Berthold A. Nock, and Marion de Jong

Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands

J Nucl Med 2021; 62:1517–1523

 

PET/MRI Improves Management of Children with Cancer

Lucia Baratto, K. Elizabeth Hawk, Lisa States, Jing Qi, Sergios Gatidis, Louise Kiru, and Heike E. Daldrup-Link

Department of Radiology, Stanford University, Stanford, California

J Nucl Med 2021; 62:1334–1340

 

Technologic (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region

Danique M.S. Berger, Nynke S. van den Berg, Vincent van der Noort, Bernies van der Hiel, Renato A. Valdés Olmos, Tessa A. Buckle, Gijs H. KleinJan, Oscar R. Brouwer, Lenka Vermeeren, Baris Karakullukçu, Michiel W.M. van den Brekel, Bart A. van de Wiel, Omgo E. Nieweg, Alfons J.M. Balm, Fijs W.B. van Leeuwen, and W. Martin C. Klop

Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute–Antoni van Leeuwenhoek, Amsterdam, The Netherlands

J Nucl Med 2021; 62:1357–1362

 

Principal-Component Analysis–Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes

Ganna Blazhenets, Lars Frings, Arnd Sörensen, and Philipp T. Meyer, for the Alzheimer’s Disease Neuroimaging Initiative

Department of Nuclear Medicine, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

J Nucl Med 2021; 62:855–860

 

Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients

Ganna Blazhenets, Nils Schroeter, Tobias Bormann, Johannes Thurow, Dirk Wagner, Lars Frings, Cornelius Weiller, Philipp T. Meyer, Andrea Dressing, and Jonas A. Hosp

Department of Nuclear Medicine, Faculty of Medicine, Medical Center–University of Freiburg, University of Freiburg, Freiburg, Germany

J Nucl Med 2021; 62:910–915

 

SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden

Yves J.L. Bodar, Berend P.F. Koene, Bernard H.E. Jansen, Matthijs C.F. Cysouw, Dennie Meijer, N. Harry Hendrikse, André N. Vis, Ronald Boellaard, and Daniela E. Oprea-Lager

Department of Urology, Amsterdam University Medical Centers, VU University, Amsterdam, The Netherlands

J Nucl Med 2021; 62:1264–1269

 

Value of 18F-FES PET in Solving Clinical Dilemmas in Breast Cancer Patients: A Retrospective Study

Jorianne Boers, Naila Loudini, Celina L. Brunsch, Sylvia A. Koza, Erik F.J. de Vries, Andor W.J.M. Glaudemans, Geke A.P. Hospers, and Carolina P. Schröder

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

J Nucl Med 2021; 62:1214–1220

 

Repurposing 11C-PS13 for PET Imaging of Cyclooxygenase-1 in Ovarian Cancer Xenograft Mouse Models

Amanda J. Boyle, Junchao Tong, Sami S. Zoghbi, Victor W. Pike, Robert B. Innis, and Neil Vasdev

Azrieli Centre for Neuro-Radiochemistry, Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada

J Nucl Med 2021; 62:665–668

 

Deep-Learning 18F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell Lymphoma

Nicolò Capobianco, Michel Meignan, Anne-Ségolène Cottereau, Laetitia Vercellino, Ludovic Sibille, Bruce Spottiswoode, Sven Zuehlsdorff, Olivier Casasnovas, Catherine Thieblemont, and Irène Buvat

Siemens Healthcare GmbH, Erlangen, Germany

J Nucl Med 2021; 62:30–36

 

Semiautomatic Tumor Delineation for Evaluation of 64Cu-DOTATATE PET/CT in Patients with Neuroendocrine Neoplasms: Prognostication Based on Lowest Lesion Uptake and Total Tumor Volume

Esben Andreas Carlsen, Camilla Bardram Johnbeck, Mathias Loft, Andreas Pfeifer, Peter Oturai, Seppo W. Langer, Ulrich Knigge, Claes Nøhr Ladefoged, and Andreas Kjaer

Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Department of Biomedical Sciences, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark

J Nucl Med 2021; 62:1564–1570

 

Patient Size-Dependent Dosimetry Methodology Applied to 18F-FDG Using New ICRP Mesh Phantoms

Lukas M. Carter, Chansoo Choi, Simone Krebs, Bradley J. Beattie, Chan Hyeong Kim, Heiko Schoder, Wesley E. Bolch, and Adam L. Kesner

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York

J Nucl Med 2021; 62:1805–1814

 

Diversity, Equity, and Inclusion in Academic Nuclear Medicine: National Survey of Nuclear Medicine Residency Program Directors

Jocelyn L. Cheng, Elizabeth H. Dibble, Grayson L. Baird, Leonie L. Gordon, and Hyewon Hyun

Department of Diagnostic Imaging, The Warren Alpert Medical School of Brown University/Rhode Island Hospital, Providence, Rhode Island

J Nucl Med 2021; 62:1207–1213

 

Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients as an Indication for Radioiodine Adjuvant Therapy: A Prospective Multicenter Study

Lin Cheng, Ri Sa, Qiong Luo, Hao Fu, Yuchen Jin, Linglin Tang, Yi Yang, Chunjing Yu, and Libo Chen

Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China

J Nucl Med 2021; 62:62–68

 

Evaluation of 18F-FDG PET and DWI Datasets for Predicting Therapy Response of Soft-Tissue Sarcomas Under Neoadjuvant Isolated Limb Perfusion

Michal Chodyla, Aydin Demircioglu, Benedikt M. Schaarschmidt, Stefanie Bertram, Nils Martin Bruckmann, Jennifer Haferkamp, Yan Li, Sebastian Bauer, Lars Podleska, Christoph Rischpler, Michael Forsting, Ken Herrmann, Lale Umutlu, and Johannes Grueneisen

Department of Diagnostic and Interventional Radiology, University Hospital Essen, University of Duisburg–Essen, Essen, Germany

J Nucl Med 2021; 62:348–353

 

18F-FLT PET/CT Adds Value to 18F-FDG PET/CT for Diagnosing Relapse After Definitive Radiotherapy in Patients with Lung Cancer: Results of a Prospective Clinical Trial

Tine Nøhr Christensen, Seppo W. Langer, Gitte Persson, Klaus Richter Larsen, Annika Loft, Annemarie Gjelstrup Amtoft, Anne Kiil Berthelsen, Helle Hjorth Johannesen, Sune Høgild Keller, Andreas Kjaer, and Barbara Malene Fischer

Department of Clinical Physiology, Nuclear Medicine, and PET, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

J Nucl Med 2021; 62:628–635

 

Mapping Arginase Expression with 18F-Fluorinated Late-Generation Arginase Inhibitors Derived from Quaternary α-Amino Acids

Gonçalo S. Clemente, Inês F. Antunes, Santosh Kurhade, Mariska P.M. van den Berg, Jürgen W.A. Sijbesma, Aren van Waarde, Rogier C. Buijsman, Nicole Willemsen-Seegers, Reinoud Gosens, Herman Meurs, Alexander Dömling, and Philip H. Elsinga

Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

J Nucl Med 2021; 62:1163–1170

Clinical Utility of 18F-FDG PET/CT for Staging and Treatment Planning in Urachal Adenocarcinoma

Jeeban P. Das, Hebert A. Vargas, Soleen Ghafoor, Alvin C. Goh, and Gary A. Ulaner

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York

J Nucl Med 2021; 62:643–647

 

PARP1: A Potential Molecular Marker to Identify Cancer During Colposcopy Procedures

Paula Demétrio de Souza França, Navjot Guru, Abigail R. Kostolansky, Audrey Mauguen, Giacomo Pirovano, Susanne Kossatz, Sheryl Roberts, Marcio Abrahão, Snehal G. Patel, Kay J. Park, Thomas Reiner, and Elizabeth Jewell

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York

J Nucl Med 2021; 62:941–948

 

A Novel Time–Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After 177Lu-DOTATATE

Theresa P. Devasia, Yuni K. Dewaraja, Kirk A. Frey, Ka Kit Wong, and Matthew J. Schipper

Department of Biostatistics, University of Michigan, Ann Arbor, Michigan

J Nucl Med 2021; 62:1118–1125

 

A Rapid and Safe Infusion Protocol for 177Lu Peptide Receptor Radionuclide Therapy

Sander C. Ebbers, Maarten W. Barentsz, Bart de Keizer, Gerard C. Krijger, Marnix G.E.H. Lam, and Arthur J.A.T. Braat

Department of Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands

J Nucl Med 2021; 62:816–822

 

Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study

Andrea Farolfi, Nader Hirmas, Andrei Gafita, Manuel Weber, Francesco Barbato, Axel Wetter, Riccardo Mei, Davide Pianori, Boris Hadaschik, Ken Herrmann, Paolo Castellucci, Stefano Fanti, Matthias Eiber, and Wolfgang P. Fendler

Nuclear Medicine Unit, University of Bologna, S. Orsola Hospital, Bologna, Italy

J Nucl Med 2021; 62:675–678

 

Volumetric PET Response Assessment Outperforms Conventional Criteria in Patients Receiving High-Dose Pembrolizumab for Malignant Mesothelioma

Justin Ferdinandus, Francesco Barbato, Michal Chodyla, Wolfgang P. Fendler, Lukas Kessler, Kelsey L. Pomykala, Martin Metzenmacher, Frederik Krefting, Thomas Hager, Lale Umutlu, Ken Herrmann, and Daniel C. Christoph

Department of Nuclear Medicine, University of Duisburg–Essen, and German Cancer Consortium–University Hospital Essen, Essen, Germany

J Nucl Med 2021; 62:191–194

Preclinical Characterization of the Radioimmunoconjugate 111In or 90Y-FF-21101 Against a P-Cadherin–Expressing Tumor in a Mouse Xenograft Model and a Nonhuman Primate

Yuichi Funase, Eri Nakamura, Masamichi Kajita, Yasutaka Saito, Shinobu Oshikiri, Michi Kitano, Masahiko Tokura, Akihiro Hino, and Tomoya Uehara

RI Research Department, Fujifilm Toyama Chemical Co., Ltd., Chiba, Japan

J Nucl Med 2021; 62:232–239

 

18F-FDG PET/CT Sheds Light on a Case of Hyponatremia

Delphine Gans, Pauline Braet, Niloefar Ahmadi Bidakhvidi, Christophe M. Deroose, Brigitte Decallonne, and Sander Jentjens

Division of Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium

J Nucl Med 2021; 62:1653–1654

 

Latest Advances in Imaging Oxidative Stress in Cancer

Hannah E. Greenwood and Timothy H. Witney

School of Biomedical Engineering and Imaging Sciences, King’s College London, London, United Kingdom

J Nucl Med 2021; 62:1506–1510

 

Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy

Patrycja Guzik, Hsin-Yu Fang, Luisa M. Deberle, Martina Benešová, Susan Cohrs, Silvan D. Boss, Simon M. Ametamey, Roger Schibli, and Cristina Müller

Center for Radiopharmaceutical Sciences, Paul Scherrer Institute, Villigen-PSI, Switzerland

J Nucl Med 2021; 62:1475–1481

 

Molecular Imaging of Very Late Antigen-4 in Acute Lung Injury

Joseph Haddad, Joseph D. Latoche, Shubhanchi Nigam, Michael C. Bellavia, Kathryn E. Day, Qin Zhu, W. Barry Edwards, Carolyn J. Anderson, and Sina Tavakoli

Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania

J Nucl Med 2021; 62:280–286

 

One-Stop Shop: 18F-Flortaucipir PET Differentiates Amyloid-Positive and -Negative Forms of Neurodegenerative Diseases

Jochen Hammes, Gérard N. Bischof, Karl P. Bohn, Özgür Onur, Anja Schneider, Klaus Fliessbach, Merle C Hönig, Frank Jessen, Bernd Neumaier, Alexander Drzezga, and Thilo van Eimeren

Multimodal Neuroimaging, Department of Nuclear Medicine, University Hospital and Medical Faculty, University of Cologne, Cologne, Germany

J Nucl Med 2021; 62:240–246

 

The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study

Sara Harsini, Heather Saprunoff, Tina Alden, Behnoud Mohammadi, Don Wilson, and François Bénard

BC Cancer, Vancouver, British Columbia, Canada

J Nucl Med 2021; 62:81–87

 

Bone Mineral Density: Clinical Relevance and Quantitative Assessment

Katherine N. Haseltine, Tariq Chukir, Pinar J. Smith, Justin T. Jacob, John P. Bilezikian, and Azeez Farooki

Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York

J Nucl Med 2021; 62:446–454

 

Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer

Kelly E. Henry, Travis M. Shaffer, Kyeara N. Mack, Janine Ring, Anuja Ogirala, Susanne Klein-Scory, Christina Eilert-Micus, Wolff Schmiegel, Thilo Bracht, Barbara Sitek, Marguerite Clyne, Colm J. Reid, Bence Sipos, Jason S. Lewis, Holger Kalthoff, and Jan Grimm

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York

J Nucl Med 2021; 62:1384–1390

 

Targeted PET Imaging of Chemokine Receptor 2–Positive Monocytes and Macrophages in the Injured Heart

Gyu Seong Heo, Geetika Bajpai, Wenjun Li, Hannah P. Luehmann, Deborah H. Sultan, Hao Dun, Florian Leuschner, Steven L. Brody, Robert J. Gropler, Daniel Kreisel, Kory J. Lavine, and Yongjian Liu

Department of Radiology, Washington University School of Medicine, St. Louis, Missouri

J Nucl Med 2021; 62:111–114

 

The Latest Advances in Imaging Crosstalk Between the Immune System and Fibrosis in Cardiovascular Disease

Gyu Seong Heo, Lanlan Lou, Deborah Sultan, and Yongjian Liu

Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri

J Nucl Med 2021; 62:1341–1346

 

68Ga-PSMA-11 PET/CT Improves Tumor Detection and Impacts Management in Patients with Hepatocellular Carcinoma

Nader Hirmas, Catherine Leyh, Miriam Sraieb, Francesco Barbato, Benedikt M. Schaarschmidt, Lale Umutlu, Michael Nader, Heiner Wedemeyer, Justin Ferdinandus, Christoph Rischpler, Ken Herrmann, Pedro Fragoso Costa, Christian M. Lange, Manuel Weber, and Wolfgang P. Fendler

Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany

J Nucl Med 2021; 62:1235–1241

 

Radionuclide Imaging of the Gut–Brain Axis in Parkinson Disease

Jacob Horsager, Karoline Knudsen, and Per Borghammer

Department of Nuclear Medicine and PET, Aarhus University Hospital, Aarhus, Denmark

J Nucl Med 2021; 62:1504-1505

 

 

The Synthesis and Structural Requirements for Measuring Glucocorticoid Receptor Expression In Vivo with (±)-11C-YJH08 PET

Yangjie Huang, Ning Zhao, Yung-hua Wang, Charles Truillet, Junnian Wei, Matthew F.L. Parker, Joseph E. Blecha, Christopher R. Drake, Henry F. VanBrocklin, Diego Garrido-Ruiz, Matthew P. Jacobson, Rahul Aggarwal, Spencer C. Behr, Robert R. Flavell, David M. Wilson, Youngho Seo, and Michael J. Evans

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California

J Nucl Med 2021; 62:723–731

 

Current Landscape in Clinical Pretargeted Radioimmunoimaging and Therapy

Vilma I.J. Jallinoja and Jacob L. Houghton

Department of Radiology, Stony Brook University, Stony Brook, New York

J Nucl Med 2021; 62:1200–1206

 

89Zr-Labeled Anti-PD-L1 Antibody PET Monitors Gemcitabine Therapy-Induced Modulation of Tumor PD-L1 Expression

Kyung-Ho Jung, Jin Won Park, Jin Hee Lee, Seung Hwan Moon, Young Seok Cho, and Kyung-Han Lee

Department of Nuclear Medicine, Samsung Medical Center, Seoul, Korea

J Nucl Med 2021; 62:656–664

 

First Experience Using 18F-Flubrobenguane PET Imaging in Patients with Suspected Pheochromocytoma or Paraganglioma

Lukas Kessler, Anna M. Schlitter, Markus Krönke, Alexander von Werder, Robert Tauber, Tobias Maurer, Simon Robinson, Cesare Orlandi, Michael Herz, Behrooz H. Yousefi, Stephan G. Nekolla, Markus Schwaiger, Matthias Eiber, and Christoph Rischpler

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg–Essen, Essen, Germany

 

68Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer

Søren Klingenberg, Mads R. Jochumsen, Benedicte P. Ulhøi, Jacob Fredsøe, Karina D. Sørensen, Michael Borre, and Kirsten Bouchelouche

Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Aarhus, Denmark

J Nucl Med 2021; 62:214–220

 

Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network

Dejan Kostyszyn, Tobias Fechter, Nico Bartl, Anca L. Grosu, Christian Gratzke, August Sigle, Michael Mix, Juri Ruf, Thomas F. Fassbender, Selina Kiefer, Alisa S. Bettermann, Nils H. Nicolay, Simon Spohn, Maria U. Kramer, Peter Bronsert, Hongqian Guo, Xuefeng Qiu, Feng Wang, Christoph Henkenberens, Rudolf A. Werner, Dimos Baltas, Philipp T. Meyer, Thorsten Derlin, Mengxia Chena, and Constantinos Zamboglou

Division of Medical Physics, Department of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

J Nucl Med 2021; 62:823–828

 

A Microdosing Study with 99mTc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients

Oana C. Kulterer, Sarah Pfaff, Wolfgang Wadsak, Nathalie Garstka, Mesut Remzi, Chrysoula Vraka, Lukas Nics, Markus Mitterhauser, Franziska Bootz, Samuele Cazzamalli, Nikolaus Krall, Dario Neri, and Alexander R. Haug

Department of Biomedical Imaging and Image-Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria

J Nucl Med 2021; 62:360–365

 

Longitudinal Molecular Imaging of Progesterone Receptor Reveals Early Differential Response to Endocrine Therapy in Breast Cancer with an Activating ESR1 Mutation

Manoj Kumar, Kelley Salem, Justin J. Jeffery, Yongjun Yan, Aparna M. Mahajan, and Amy M. Fowler

Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin

J Nucl Med 2021; 62:500–506

 

177Lu-Labeled Albumin-Binder–Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio

Hsiou-Ting Kuo, Kuo-Shyan Lin, Zhengxing Zhang, Carlos F. Uribe, Helen Merkens, Chengcheng Zhang, and François Bénard

Department of Molecular Oncology, BC Cancer, Vancouver, British Columbia, Canada

J Nucl Med 2021; 62:521–527

 

Simulation of Low-Dose Protocols for Myocardial Perfusion 82Rb Imaging

Martin Lyngby Lassen, Yuka Otaki, Paul Kavanagh, Robert J.H. Miller, Daniel S. Berman, and Piotr J. Slomka

Department of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, California

J Nucl Med 2021; 62:1112–1117

 

Nondisplaceable Binding Is a Potential Confounding Factor in 11C-PBR28 Translocator Protein PET Studies

Gjertrud L. Laurell, Pontus Plavén-Sigray, Aurelija Jucaite, Andrea Varrone, Kelly P. Cosgrove, Claus Svarer, Gitte M. Knudsen, Karolinska Schizophrenia Project Consortium, R. Todd Ogden, Francesca Zanderigo, Simon Cervenka, Ansel T. Hillmer, and Martin Schain

Neurobiology Research Unit, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark

J Nucl Med 2021; 62:412–417

Peptide Receptor Radionuclide Therapy of Late-Stage Neuroendocrine Tumor Patients with Multiple Cycles of 177Lu-DOTA-EB-TATE

Qingxing Liu, Jie Zang, Huimin Sui, Jiakun Ren, Hua Guo, Hao Wang, Rongxi Wang, Orit Jacobson, Jingjing Zhang, Yuejuan Chengy, Zhaohui Zhuy, and Xiaoyuan Cheny

Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China

J Nucl Med 2021; 62:386–392

 

64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After Injection

Mathias Loft, Esben A. Carlsen, Camilla B. Johnbeck, Helle H. Johannesen, Tina Binderup, Andreas Pfeifer, Jann Mortensen, Peter Oturai, Annika Loft, Anne K. Berthelsen, Seppo W. Langer, Ulrich Knigge, and Andreas Kjaer

Department of Clinical Physiology, Nuclear Medicine, and PET and Cluster for Molecular Imaging, Department of Biomedical Sciences, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark

J Nucl Med 2021; 62:73–80

 

Cyclotron Production and Separation of Scandium Radionuclides from Natural Titanium Metal and Titanium Dioxide Targets

Shaun Loveless, Jose R. Blanco, George L. Diehl III, Rawdah T. Elbahrawi, Tommaso S. Carzaniga, Saverio Braccini, and Suzanne E. Lapi

Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama

J Nucl Med 2021; 62:131–136

 

Imaging Immunometabolism in Atherosclerosis

Philip Z. Mannes and Sina Tavakoli

Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania

J Nucl Med 2021; 62:896–902

 

Repurposing 99mTc-Mebrofenin as a Probe for Molecular Imaging of Hepatocyte Transporters

Solène Marie, Irene Hernández-Lozano, Oliver Langer, and Nicolas Tournier

Laboratoire d’Imagerie Biomédicale Multimodale, BioMaps, Université Paris-Saclay, CEA, CNRS, INSERM, Service Hospitalier Frédéric Joliot, Orsay, France

J Nucl Med 2021; 62:1043–1047

 

Distinguishing Primary Lateral Sclerosis from Parkinsonian Syndromes with the Help of Advanced Imaging

Pegah Masrori, Donatienne Van Weehaeghe, Koen Van Laere, and Philip Van Damme

Neuromuscular Reference Centre, Department of Neurology, University Hospitals Leuven, Leuven, Belgium

J Nucl Med 2021; 62:1318–1319

 

Diagnostic Value, Oncologic Outcomes, and Safety Profile of Image-Guided Surgery Technologies During Robot-Assisted Lymph Node Dissection with Sentinel Node Biopsy for Prostate Cancer

Elio Mazzone, Paolo Dell’Oglio, Nikos Grivas, Esther Wit, Maarten Donswijk, Alberto Briganti, Fijs Van Leeuwen, and Henk van der Poel

Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy

J Nucl Med 2021; 62:1363–1371

 

Biochemical Persistence of Prostate-Specific Antigen After Robot-Assisted Laparoscopic Radical Prostatectomy: Tumor Localizations Using PSMA PET/CT Imaging

Dennie Meijer, Maarten L. Donswijk, Yves J.L. Bodar, Pim J. van Leeuwen, Henk G. van der Poel, Wouter V. Vogel, Jakko A. Nieuwenhuijzen, N. Harry Hendrikse, Daniela E. Oprea-Lager, and André N. Vis

Department of Urology, Amsterdam University Medical Center, VU University, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands

J Nucl Med 2021; 62:961–967

Assessing Response to 177Lu-PSMA Radioligand Therapy Using Modified PSMA PET Progression Criteria

Kerstin Michalski, Claudius Klein, Tonio Brüggemann, Philipp T. Meyer, Cordula A. Jilg, and Juri Ruf

Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany

J Nucl Med 2021; 62:1741–1746

 

Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model

Megan Minnix, Vikram Adhikarla, Enrico Caserta, Erasmus Poku, Russell Rockne, John E. Shively, and Flavia Pichiorri

Department of Molecular Imaging and Therapy, Beckman Research Institute, City of Hope, Duarte, California

J Nucl Med 2021; 62:795–801

 

TAG-72–Targeted α-Radionuclide Therapy of Ovarian Cancer Using 225Ac-Labeled DOTAylated-huCC49 Antibody

Megan Minnix, Lin Li, Paul J. Yazaki, Aaron D. Miller, Junie Chea, Erasmus Poku, An Liu, Jeffrey Y.C. Wong, Russell C. Rockne, David Colcher, and John E. Shively

Department of Molecular Imaging and Therapy, Beckman Research Institute, City of Hope, Duarte, California

J Nucl Med 2021; 62:55–61

 

Determining the Axillary Nodal Status with 4 Current Imaging Modalities, Including 18F-FDG PET/MRI, in Newly Diagnosed Breast Cancer: A Comparative Study Using Histopathology as the 
Reference Standard

Janna Morawitz, Nils-Martin Bruckmann, Frederic Dietzel, Tim Ullrich, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Lena Häberle, Marc Ingenwerth, Lale Umutlu, Wolfgang Peter Fendler, Tanja Fehm, Ken Herrmann, Gerald Antoch, Lino Morris Sawicki, and Julian Kirchner

Department of Diagnostic and Interventional Radiology, University of Dusseldorf, Dusseldorf, Germany

J Nucl Med 2021; 62:1677–1683

 

Prognostic Value of Bone Marrow Metabolism on Pretreatment 18F-FDG PET/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy

Ryusuke Nakamoto, Lisa C. Zaba, Tie Liang, Sunil Arani Reddy, Guido Davidzon, Carina Mari Aparici, Judy Nguyen, Farshad Moradi, Andrei Iagaru, and Benjamin Lewis Franc

Department of Radiology, Stanford University, Stanford, California

J Nucl Med 2021; 62:1380–1383

A Noninvasive Method for Quantifying Cerebral Metabolic Rate of Oxygen by Hybrid PET/MRI: Validation in a Porcine Model

Lucas Narciso, Tracy Ssali, Linshan Liu, Heather Biernaski, John Butler, Laura Morrison, Jennifer Hadway, Jeffrey Corsaut, Justin W. Hicks, Michael C. Langham, Felix W. Wehrli, Hidehiro Iida, and Keith St Lawrence

Lawson Health Research Institute, London, Ontario, Canada

J Nucl Med 2021; 62:1789–1796

 

Repeatability of Radiomic Features of Brown Adipose Tissue

Aria Nazeri, John P. Crandall, Tyler J. Fraum, and Richard L. Wahl

Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri

J Nucl Med 2021; 62:700–706

 

Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial

Marie Øbro Fosbøl, Sorel Kurbegovic, Helle Hjorth Johannesen, Martin Andreas Røder, Adam Espe Hansen, Jann Mortensen, Annika Loft, Peter Meidahl Petersen, Jacob Madsen, Klaus Brasso, and Andreas Kjaer

Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark

J Nucl Med 2021; 62:354–359

 

Quantitative 68Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with 177Lu-DOTATATE

Claudia Ortega, Rebecca K.S. Wong, Josh Schaefferkoetter, Patrick Veit-Haibach, Sten Myrehaug, Rosalyn Juergens, David Laidley, Reut Anconina, Amy Liu, and Ur Metser

Joint Department of Medical Imaging, University Health Network, Mount Sinai Hospital and Women’s College Hospital, University of Toronto, Toronto, Ontario, Canada

J Nucl Med 2021; 62:1406–1414

 

Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition

Patricia M.R. Pereira, Jalen Norfleet, Jason S. Lewis, and Freddy E. Escorcia

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York

J Nucl Med 2021; 62:366–371

 

Molecular Imaging: PARP-1 and Beyond

Laura N. Puentes, Mehran Makvandi, and Robert H. Mach

Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania

J Nucl Med 2021; 62:765–770

 

Optoacoustic Imaging of Glucagon-like Peptide-1 Receptor with a Near-Infrared Exendin-4 Analog

Sheryl Roberts, Eshita Khera, Crystal Choi, Tejas Navaratna, Jan Grimm, Greg M. Thurber, and Thomas Reiner

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York

J Nucl Med 2021; 62:839–848

Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas

Manuel Röhrich, Patrick Naumann, Frederik L. Giesel, Peter L. Choyke, Fabian Staudinger, Annika Wefers, Dawn P. Liew, Clemens Kratochwil, Hendrik Rathke, Jakob Liermann, Klaus Herfarth, Dirk Jäger, Jürgen Debus, Uwe Haberkorn, Matthias Lang, and Stefan A. Koerber

Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany

J Nucl Med 2021; 62:779–786

 

Dopaminergic Nigrostriatal Connectivity in Early Parkinson Disease: In Vivo Neuroimaging Study of 11C-DTBZ PET Combined with Correlational Tractography

Carlos A. Sanchez-Catasus, Nicolaas I. Bohnen, Fang-Cheng Yeh, Nicholas D’Cruz, Prabesh Kanel, and Martijn L.T.M. Müller

Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan

J Nucl Med 2021; 62:545–552

 

Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients

Melline G.M. Schilham, Patrik Zamecnik, Bastiaan M. Privé, Bas Israël, Mark Rijpkema, Tom Scheenen, Jelle O. Barentsz, James Nagarajah, and Martin Gotthardt

Department of Medical Imaging, Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands

J Nucl Med 2021; 62:1258–1263

 

Minimal Extrathyroidal Extension in Papillary Thyroid Microcarcinoma Is an Independent Risk Factor for Relapse Through Lymph Node and Distant Metastases

Robert Seifert, Michael Schäfers, Barbara Heitplatz, Laura Kerschke, Burkhard Riemann, and Benjamin Noto

Department of Nuclear Medicine, University Hospital Münster, Münster, Germany

J Nucl Med 2021; 62:1702–1709

 

Fluorescence-Guided Visualization of Soft-Tissue Sarcomas by Targeting Vascular Endothelial Growth Factor A: A Phase 1 Single-Center Clinical Trial

Pieter J. Steinkamp, Bobby K. Pranger, Mei-Fang Li, Matthijs D. Linssen, Floris J. Voskuil, Lukas B. Been, Barbara L. van Leeuwen, Albert J.H. Suurmeijer, Wouter B. Nagengast, Schelto Kruijff, Robert J. van Ginkel, and Gooitzen M. van Dam

Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

J Nucl Med 2021; 62:342–347

 

Mesothelin/CD3 Half-Life–Extended Bispecific T-Cell Engager Molecule Shows Specific Tumor Uptake and Distributes to Mesothelin and CD3-Expressing Tissues

Frans V. Suurs, Grit Lorenczewski, Julie M. Bailis, Sabine Stienen, Matthias Friedrich, Fei Lee, Bert van der Vegt, Elisabeth G.E. de Vries, Derk Jan A. de Groot, and Marjolijn N. Lub-de Hooge

Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands

J Nucl Med 2021; 62:1797–1804

 

Relationship Between Tau and Cognition in the Evolution of Alzheimer’s Disease: New Insights from Tau PET

Jeremy A. Tanner and Gil D. Rabinovici

Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California

J Nucl Med 2021; 62:612–613

Voxelwise and Patientwise Correlation of 18F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes

Hiroyuki Tatekawa, Akifumi Hagiwara, Jingwen Yao, Talia C. Oughourlian, Issei Ueda, Hiroyuki Uetani, Catalina Raymond, Albert Lai, Timothy F. Cloughesy, Phioanh L. Nghiemphu, Linda M. Liau, Whitney B. Pope, Noriko Salamon, and Benjamin M. Ellingson

UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, UCLA, Los Angeles, California

J Nucl Med 2021; 62:319–325

 

Determining Amyloid-β Positivity Using 18F-AZD4694 PET Imaging

Joseph Therriault, Andrea L. Benedet, Tharick A. Pascoal, Melissa Savard, Nicholas J. Ashton, Mira Chamoun, Cecile Tissot, Firoza Lussier, Min Su Kang, Gleb Bezgin, Tina Wang, Jaime Fernandes-Arias, Gassan Massarweh, Paolo Vitali, Henrik Zetterberg, Kaj Blennow, Paramita Saha-Chaudhuri, Jean-Paul Soucy, Serge Gauthier, and Pedro Rosa-Neto

Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Montreal, Quebec, Canada

J Nucl Med 2021; 62:247–252

 

Liver Enzyme Elevation After 177Lu-PSMA Radioligand Therapy for Metastasized Castration-Resistant Prostate Cancer

Hannes Treiber, Alexander König, Albrecht Neesse, Annika Richter, Carsten Oliver Sahlmann, and Arne Strauss

Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany

J Nucl Med 2021; 62:1016–1019

 

Surveillance of Clinically Complete Responders Using Serial 18F-FDG PET/CT Scans in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy

Maria J. Valkema, Berend J. van der Wilk, Ben M. Eyck, Bas P.L. Wijnhoven, Manon C.W. Spaander, Michail Doukas, Sjoerd M. Lagarde, Wendy M.J. Schreurs, Mark J. Roef, J. Jan B. van Lanschot, and Roelf Valkema

Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands

J Nucl Med 2021; 62:486–492

 

Assessment of Bone Lesions with 18F-FDG PET Compared with 99mTc Bone Scintigraphy Leads to Clinically Relevant Differences in Metastatic Breast Cancer Management

Suzanne C. van Es, Ton Velleman, Sjoerd G. Elias, Frederike Bensch, Adrienne H. Brouwers, Andor W.J.M. Glaudemans, Thomas C. Kwee, Marleen Woltman-van Iersel, John H. Maduro, Sjoukje F. Oosting, Elisabeth G.E. de Vries, and Carolina P. Schröder

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

J Nucl Med 2021; 62:177–183

 

A Model System to Explore the Detection Limits of Antibody-Based Immuno-SPECT Imaging of Exclusively Intranuclear Epitopes

Mathew Veal, Gemma Dias, Veerle Kersemans, Deborah Sneddon, Stephen Faulkner, and Bart Cornelissen

Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom

J Nucl Med 2021; 62:1537–1544

 

First-in-Humans Study of 68Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1

Riikka Viitanen, Olli Moisio, Petteri Lankinen, Xiang-Guo Li, Mikko Koivumäki, Sami Suilamo, Tuula Tolvanen, Kirsi Taimen, Markku Mali, Ia Kohonen, Ilpo Koskivirta, Vesa Oikonen, Helena Virtanen, Kristiina Santalahti, Anu Autio, Antti Saraste, Laura Piril, Pirjo Nuutila, Juhani Knuuti, Sirpa Jalkanen, and Anne Roivainen

Turku PET Centre, University of Turku, Turku, Finland

J Nucl Med 2021; 62:577–583

 

Kinetic Modeling of 18F-(2S,4R)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism

Varsha Viswanath, Rong Zhou, Hsiaoju Lee, Shihong Li, Abigail Cragin, Robert K. Doot, David A. Mankoff, and Austin R. Pantel

Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania

J Nucl Med 2021; 62:1154–1162

 

Metallofluorocarbon Nanoemulsion for Inflammatory Macrophage Detection via PET and MRI

Chao Wang, Benjamin I. Leach, Deanne Lister, Stephen R. Adams, Hongyan Xu, Carl Hoh, Patrick McConville, Jing Zhang, Karen Messer, and Eric T. Ahrens

Department of Radiology, University of California San Diego, La Jolla, California

J Nucl Med 2021; 62:1146–1153

 

PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center Study

Manuel Weber, Claudia Kurek, Francesco Barbato, Matthias Eiber, Tobias Maurer, Michael Nader, Boris Hadaschik, Viktor Grünwald, Ken Herrmann, Axel Wetter, and Wolfgang P. Fendler

Department of Nuclear Medicine, University of Duisburg–Essen, and German Cancer Consortium–University Hospital Essen, Essen, Germany

J Nucl Med 2021; 62:88–91

 

Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy

Christopher E. Wee, Ayca Dundar, Rachel A. Eiring, Mohamed Badawy, Timothy J. Hobday, A. Tuba Kendi, Annie T. Packard, and Thorvardur R. Halfdanarson

Mayo Clinic, Rochester, Minnesota

J Nucl Med 2021; 62:1320

 

Lymph Node Staging with a Combined Protocol of 18F-FDG PET/MRI and Sentinel Node SPECT/CT: A Prospective Study in Patients with FIGO I/II Cervical Carcinoma

Matthias Weissinger, Florin-Andrei Taran, Sergios Gatidis, Stefan Kommoss, Konstantin Nikolaou, Samine Sahbai, Christian la Fougère, Sara Yvonne Brucker, and Helmut Dittmann

Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany

J Nucl Med 2021; 62:1062–1067

 

High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT

Rudolf A. Werner, Thorsten Derlin, Steven P. Rowe, Lena Bundschuh, Gabriel T. Sheikh, Martin G. Pomper, Sebastian Schulz, Takahiro Higuchi, Andreas K. Buck, Frank M. Bengel, Ralph A. Bundschuh, and Constantin Lapa

Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany

J Nucl Med 2021; 62:514–520

 

Assessment and Comparison of 18F-Fluorocholine PET and 99mTc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis

Julia Whitman, Isabel E. Allen, Emily K. Bergsland, Insoo Suh, and Thomas A. Hope

Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California

J Nucl Med 2021; 62:1285–1291

Direct Attenuation Correction Using Deep Learning for Cardiac SPECT: A Feasibility Study

Jaewon Yang, Luyao Shi, Rui Wang, Edward J. Miller, Albert J. Sinusas, Chi Liu, Grant T. Gullberg, and Youngho Seo

Physics Research Laboratory, Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California

J Nucl Med 2021; 62:1645–1652

 

First Clinical Results for PSMA-Targeted α-Therapy Using 225Ac-PSMA-I&T in Advanced-mCRPC Patients

Mathias Johannes Zacherl, Franz Josef Gildehaus, Lena Mittlmeier, Guido Böning, Astrid Gosewisch, Vera Wenter, Marcus Unterrainer, Nina Schmidt-Hegemann, Claus Belka, Alexander Kretschmer, Jozefina Casuscelli, Christian G. Stief, Marcus Unterrainer, Peter Bartenstein, Andrei Todica, and Harun Ilhan

Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany

J Nucl Med 2021; 62:669–674

 

Ferronostics: Measuring Tumoral Ferrous Iron with PET to Predict Sensitivity to Iron-Targeted Cancer Therapies

Ning Zhao, Yangjie Huang, Yung-hua Wang, Ryan K. Muir, Ying-Chu Chen, Junnian Wei, Nima Hooshdaran, Pavithra Viswanath, Youngho Seo, Davide Ruggero, Adam R. Renslo, and Michael J. Evans

Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California

J Nucl Med 2021; 62:949–955

 

Site-Specific and Residualizing Linker for 18F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment

Zhengyuan Zhou, Rebecca Meshaw, Michael R. Zalutsky, and Ganesan Vaidyanathan

Department of Radiology, Duke University Medical Center, Durham, North Carolina

J Nucl Med 2021; 62:1624–1630

SNMMI JNM Best Paper Awards

Editors’ Choice Award

FOR THE BEST CLINICAL ARTICLE IN 2021

is presented to

Manuel Röhrich, Patrick Naumann, Frederik L. Giesel, Peter L. Choyke, Fabian Staudinger, Annika Wefers, Dawn P. Liew, Clemens Kratochwil, Hendrik Rathke, Jakob Liermann, Klaus Herfarth, Dirk Jäger, Jürgen Debus, Uwe Haberkorn, Matthias Lang, and Stefan A. Koerber

Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany

for

Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas

J Nucl Med. 2021; 62:779–786

 

The Journal of Nuclear Medicine

Editors’ Choice Award

FOR THE BEST BASIC SCIENCE ARTICLE IN 2021

is presented to

Mark G. MacAskill, Agne Stadulyte, Lewis Williams, Timaeus E.F. Morgan, Nikki L. Sloan, Carlos J. Alcaide-Corral, Tashfeen Walton, Catriona Wimberley, Chris-Anne McKenzie, Nick Spath, William Mungall, Ralph BouHaidar, Marc R. Dweck, Gillian A. Gray, David E. Newby, Christophe Lucatelli, Andrew Sutherland, Sally L. Pimlott, and Adriana A.S. Tavares

University/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom

for

Quantification of Macrophage-Driven Inflammation During Myocardial Infarction with 18F-LW223, a Novel TSPO Radiotracer with Binding Independent of the rs6971 Human Polymorphism

J Nucl Med. 2021; 62:536–544

 

The Journal of Nuclear Medicine

Editors’ Choice Award

FOR THE OVERALL BEST ARTICLE IN 2021

is presented to

Manuel Röhrich, Patrick Naumann, Frederik L. Giesel, Peter L. Choyke, Fabian Staudinger, Annika Wefers, Dawn P. Liew, Clemens Kratochwil, Hendrik Rathke, Jakob Liermann, Klaus Herfarth, Dirk Jäger, Jürgen Debus, Uwe Haberkorn, Matthias Lang, and Stefan A. Koerber

Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany

for

Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas

J Nucl Med. 2021; 62:779–786

Susan C. Weiss Clinical Advancement Scholarship - n/a 2022

ERF-SNMMI-TS Bachelor's or Master's Degree Completion Scholarship - Angela Weiler, CNMT and Diane Soulek, CNMT

ERF-SNMMI-TS Advanced Degree Scholarship - Sarah Frye, CNMT

Paul Cole Student Technologist Scholarship - Fernando Anleu, Dylan Cooper, Rebecca Covey, Allison Knuth, Ashley LaGrone, Mikaya Rodgers, Bridget Russell, Bryn Schlender, Marina Steele, Teagan White

ERF-SNMMI-TS Outstanding Technologist

Kathy Thompson Hunt Outstanding Educator Award - 

ERF-SNMMI-TS JNMT Best Paper Awards

Editors’ Choice Award

FOR 1ST PLACE ARTICLE IN 2021

is presented to

Shannon N. Youngblood

University of Arkansas for Medical Sciences, Little Rock, Arkansas, and Ochsner Medical Center, Baton Rouge, Louisiana

for

Bullying in the Nuclear Medicine Department and During Clinical Nuclear Medicine Education

J Nucl. Med. Technol. 2021; 49:156–163

 

Editors’ Choice Award

FOR 2ND PLACE ARTICLE IN 2021

is presented to

Kyohei Okuda, Daisuke Hasegawa, Takashi Kamiya, Hajime Ichikawa, Takuro Umeda, Takushi Ohkubo, and Kenta Miwa

Department of Clinical Radiology, Tottori University Hospital, Yonago, Japan

for

Multicenter Study of Quantitative SPECT: Reproducibility of 99mTc Quantitation Using a Conjugated-Gradient Minimization Reconstruction Algorithm

J Nucl. Med. Technol. 2021; 49:138–142

 

Editors’ Choice Award

FOR 3RD PLACE ARTICLE IN 2021

is presented to

Pietro Paolo de Barros, Tatiane Sabriela Cagol Camozzato, Tiago Jahn, Flávio Augusto Penna Soares, Letícia Machado da Silva, Jacqueline de Aguiar Soares, and Marco Antonio Neiva Koslosky

Federal Institute of Education, Science, and Technology of Santa Catarina–IFSC, Florianópolis, Santa Catarina, Brazil

for

Analysis of Radiometry on Patients Undergoing Radioactive Iodine Therapy

J Nucl. Med. Technol. 2021; 49:75–81

 

Editors’ Choice Award

FOR BEST CONTINUING EDUCATION ARTICLE IN 2021

is presented to

Julie Bolin

Nuclear Medicine Technology Program, GateWay Community College, Phoenix, Arizona

for

Thyroid Follicular Epithelial Cell–Derived Cancer: New Approaches and Treatment Strategies

J Nucl. Med. Technol. 2021; 49:199–208

 

Editors’ Choice Award

FOR BEST EDUCATORS’ FORUM ARTICLE IN 2021

is presented to

George Patchoros and Grace Wenzler

Department of Engineering, Physics, and Technology, Bronx Community College, Bronx, New York

for

Satisfying Program-Level Outcomes by Integrating Primary Literature into the Online Classroom

J Nucl. Med. Technol. 2021; 49:170–174

2022 Grants and Awards Recipients (funded by the Nihon Medi-Physics)

2022-2024 Wagner-Torizuka Fellowship Program - n/a 2022

2022 Grant Recipients (funded by the SNMMI Value Initiative)

Medical and Science Student Research Grant - Shirley Chen, Junyu Chen, Yuchen Dai, Roberto Fedrigo, Yan Liu, Noah Nigh, Ali Fele Paranj, Divya Ramakrishnan

Co-op Research Grant

Radiopharmaceutical Therapy Fellowship - Sophia O'Brien, MD and Ashwin Singh Parihar, MBBS, MD

2022 Grants and Awards Recipients (funded by the PDEF)

PDEF Mickey Williams Minority ScholarshipFernando Anleu and Shanton Register

PDEF Professional Development ScholarshipDerrick Gillan, ARRT(N)(MR)(CT)PET

2022 Council and Center Awards

Saul Hertz AwardAndrew M. Scott, MD, FRACP, FAANMS

Peter E. Valk, MD Memorial Lecuteship/AwardJohannes Czernin, MD

GCNMC Lifetime Achievement AwardShankar Vallabhajosula, PhD

GCNMC Lectureship Award - Christopher Palestro, MD, FACNM, FSNMMI

CIC Barry Siegel Lectureship Award - David Schuster, MD, FACR

Tracey Lynn Faber Award - Emilie Roncali, PhD

Edward Hoffman Lecture Award - Margaret Daube-Witherspoon, PhD

Kuhl Lassen AwardGil Rabinovici, MD

Berson-Yalow Award - Cassis Varlow, BSc

Hermann Blumgart Award - Andrew Einstein, MD, PhD, FACC, FAHA

CVC Outstanding Educator Award - Prem Soman, MD, PhD

AC Lifetime Achievement Award - Virginia Pappas, CAE

AC Distinguished Service Award - Erin Grady, MD, CCD, FACNM

PIC Conway-Treves Award - n/a 2022

Sally W. Schwarz Award - Neil A. Petry, MS, RPh, BCNP, FAPhA